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Abstract
Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by abnormal accumulation 
of a lipoproteinaceous material in the alveoli, which may lead to respiratory failure and has an 
associated high risk for infections. The mainstay treatment for PAP is whole lung lavage.
A pregnant woman, previously diagnosed with primary PAP, the most common form of PAP, was 
admitted with dyspnea and worsening respiratory function. In one month period, a wholelung 
bronchopulmonary lavage was performed twice, with clinical and functional improvement. 
Pregnancy was carried to term and a healthy baby was delivered.
The mechanisms of respiratory impairment are discussed as well as treatment options and 
response.
© 2010 Published by Elsevier España, S.L. on behalf of Sociedade Portuguesa de Pneumologia. 
All rights reserved.
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Resumo
A proteinose alveolar pulmonar (PAP) é uma doença rara caracterizada pela acumulação anormal 
de material lipoproteináceo nos alvéolos, que pode levar a insufi ciência respiratória, estando 
associada a um risco elevado de infecções. O tratamento gold-standard da PAP é a lavagem 
pulmonar total.
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Uma mulher grávida, com diagnóstico prévio de PAP primária, a forma mais comum de PAP, foi 
internada com um quadro de dispneia e agravamento da função respiratória. No período de um 
mês, foi realizada lavagem pulmonar total duas vezes, com melhoria clínica e funcional. 
A gravidez foi levada a termo, com o nascimento de um bebé saudável.
Os mecanismos de comprometimento respiratório são discutidos, bem como as opções de 
tratamento e resposta.
© 2010 Publicado por Elsevier España, S.L. em nome da Sociedade Portuguesa de Pneumologia. 
Todos os direitos reservados.
Introduction
PAP is a rare disorder, characterized by abnormal 
accumulation of a lipoproteinaceous material in alveoli, 
with minimal interstitial infl ammation or fi brosis. There is 
an increased risk of respiratory infections and clinical course 
may vary between stable disease with persistent symptoms, 
spontaneous improvement, and progressive disease evolving 
to respiratory failure. Whole-lung broncho-pulmonary 
lavage (BPL) has been the gold standard treatment since 
the 1960s.
We report a successful full-term pregnancy in a 
patient with progressive PAP, whose pulmonary function 
deterioration evolved to such severe respiratory failure, 
that a whole-lung BPL was necessary. In the literature, a 
sole case of BPL has been described in a pregnant woman.
Case report
The patient was a 44-year-old black woman, obese and 
hypertensive, controlled with nifedipine. She had seven 
previous pregnancies including one spontaneous abortion and 
one hydatiform mole. One of her children died from brain 
cell astrocytoma and the remaining four were healthy.
Two years before admission, she had been diagnosed with 
primary PAP after investigation of complaints of exertional 
dyspnea, cough and mucous sputum for fi ve months. The 
diagnosis was based on compatible imaging studies (chest 
tomography showing interstitial infi ltrates and “crazy paving” 
aspect) and characteristic milky bronchoalveolar-lavage 
(BAL) fluid with granular material staining with periodic 
acid-Schiff. Respiratory function test showed a forced 
expiratory volume in the first second of 1,17L (57 % of 
predicted), a Tiffeneau index of 65 % and total lung capacity 
of 3,31L (63 % of predicted). Diffusing capacity (DLCO) was 
35 % of predicted. A right whole-lung BPL was performed 
in May 2004, when symptoms and arterial blood gas (ABG) 
parameters worsened (Table 1). After this procedure she 
remained asymptomatic until dyspnea recurred in October 
2004, when she refused a new lavage.
In September 2005, she went to a local hospital with a 
progressive dyspnea, cough and copious yellow sputum for 
the previous 4 weeks, fever for 10 days and amenorrhea 
for 3 months. Antibiotic treatment was unsuccessful, and 
she was transferred to our hospital due to progressive 
respiratory failure.
Initial examination revealed obesity (Body mass index of 
35), tachypnea, and bibasilar crackles. She had neither ankle 
edema nor orthopnea. ABG revealed hypoxemic respiratory 
failure (Table 1). A leucocytosis of 14400/mL and a normal 
hemoglobin level were present. Chest radiograph illustrated 
alveolar infiltrates in the inferior thirds bilaterally. 
Electrocardiogram and saline contrast echocardiogram were 
normal, excluding right-to-left circulatory shunt; Both BAL 
fl uid (that displayed the characteristic pathologic features 
of PAP) and blood microbiologic cultures were negative. 
Although treatment with meropenem resolved leucocytosis, 
hypoxia persisted and a FiO2 of 40-50 % was necessary to 
maintain SatO2 above 90 %.
An eight-week pregnancy was disclosed by ultrasound. It was 
the fi rst pregnancy after the diagnosis of PAP. The risks of life 
threatening complications were discussed with the patient, 
who decided to keep the pregnancy and agreed to perform 
a right whole-lung BPL. The procedure was done in October 
6th according to the protocol described by Ben-Abraham in an 
operating room under general anesthesia and hemodynamic 
and ventilatory monitoring; almost all of the 9,5L of the 
instilled fl uid was recovered and SatO2 remained always above 
90 %. Improvement in respiratory failure was notorious as she 
decreased the need of oxygen supplements substantially until 
her release fi ve days later (Table 1).
Poor compliance to prescribed oxygen (3 L/min) and 
aggravation of dyspnea were reported at follow-up 
appointment two weeks later. Gas exchange worsened 
(Table 1), but there were no signs of infection. She was 
readmitted for left whole-lung BPL (Fig. 1) with 14 L of 
saline on October 27th (13th week of gestation). After the 
procedure, although a gas exchange improvement was 
observed, she remained on oxygen (Table 1). The patient 
was discharged on oxygen at 4 L/min and was closely 
monitored for the next 13 weeks by Internal medicine and 
obstetric teams.
On the 26th week of pregnancy, due to progressive 
dyspnea, the patient was re-admitted and received oxygen 
through nonrebreathing mask to maintain SatO2 above 93 %. 
Due to superimposed preeclampsia and breech presentation, 
a cesarean was performed under epidural anesthesia on 
the 37th week, and a healthy female baby was delivered. 
Throughout all the procedures SatO2 remained above 90 %. 
Postpartum SatO2 was 98 % with a FiO2 of 31 %, and improved 
in the next six months (SatO2 of 98 % on air).
With time, gas exchange and chest radiography tended 
to deteriorate (Table 1). On February 2007 a new BPL 
was performed sequentially in both lungs, resulting in 
signifi cant improvement in gas exchange and two months 
later she dropped oxygen supplements (Table 1). Three 
years later the patient is asymptomatic and with no need 
of oxygen supplements, while the child exhibits a normal 
development.
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Discussion
This case of PAP turned out to be very challenging due 
to the need to manage a pregnant patient with severe 
hypoxemia in which both treatment and ongoing pregnancy 
could induce, at least temporarily, a decline in respiratory 
function. We found a single case of successful whole-lung 
BPL during pregnancy described in the literature in a young 
pregnant woman with PAP but healthy otherwise. In our 
patient, maternal age, hypertension and obesity increased 
pregnancy risk, making decisions even more diffi cult.
She presented eight weeks pregnant with respiratory 
failure and although respiratory infection may have 
contributed to functional aggravation, it was probably 
not a preponderant factor, since an improvement was not 
observed after its resolution. Moreover, later in pregnancy, 
gas exchange worsening was also observed in the absence of 
infection. Other causes for the refractory respiratory failure 
in pregnancy like cardiac failure or right-to-left circulatory 
shunt were discarded.
Although progression of PAP can not be excluded, the 
sudden deterioration of pulmonary function coinciding with 
the beginning of pregnancy and the persistence of respiratory 
impairment despite pulmonary lavage, suggest that 
pregnancy had an important role in worsening respiratory 
failure. Throughout normal pregnancy, anatomical, 
biochemical and hormonal changes cause adaptations in 
the respiratory system that compensate for the increased 
demands of fetal growth and development. These changes are 
usually well tolerated, however in the setting of underlying 
pulmonary disease they can lead to deterioration of an 
already impaired respiratory function. Elevated diaphragms 
Table 1 Arterial blood gases
Date Measurement 
 FiO2 pH PaCO2 (mmHg) PaO2 (mmHg) SatO2
May/2004
 Before RL lavage
21 % 7.46 30  64 94 %
Pregnancy
 26/09/05
 admission
31 % 7.49 23  53 90 %
  11/10/05
After RL lavage
21 % 7.47 27  55 92 %
  25/10/05
Before LL lavage
21 % 7.43 25  45 84 %
  02/11/05
After LL lavage
5 L/min 7.41 32  83 96 %
After pregnancy
  14/02/07
Before BLL
21 % 7.40 42  41 73 %
  16/02/07
After BLL
21 % 7.45 35  65 94 %
  09/04/07
2 month Follow-up
21 % 7.46 23 105 98 %
BLL: bilateral lung lavage; FiO2: fraction of inspired oxygen; LL: left lung; PaCO2: arterial carbon dioxide tension (mmHg); PaO2: 
arterial oxygen tension (mmHg); RL: right lung; SatO2: oxygen saturation.
in pregnancy can induce microatelectasis in lower lobes, 
which could aggravate the ventilation-perfusion mismatch 
and consequently exacerbate hypoxemia, especially in a 
patient with ventilatory restriction and severe decrease in 
DLCO.
Interestingly, PAP has been associated with impaired 
function of alveolar macrophages (which are responsible for 
surfactant turnover), caused by auto-antibodies directed 
at GM-CSF, and is also associated with immunodefi ciency 
states. On the other hand, during pregnancy, besides 
anatomical and biochemical adaptations, several changes 
occur in almost every aspect of the immune system. For 
instance, these changes are believed to modify the course 
of auto-immune diseases due to alterations in the activity 
of some immunity cells. Hence it is possible to reason that 
the known immunomodulation occurring in pregnancy 
could contribute to impaired macrophage function (with 
additional imbalance in surfactant homeostasis), thereby 
worsening clinical condition. This could explain ventilatory 
decline at an early stage of pregnancy, when the infl uence 
of the uterus growth is not yet noticed. Further studies are 
required to clarify this question.
BPL, the gold-standard treatment for PAP, is described as 
safe and effi cient, resulting in increased survival. It can be 
performed one lung at a time or in both lungs sequentially if 
patient is considered to tolerate one-lung ventilation of the 
lung that has just been treated. 10,11 Improvement in arterial 
oxygen tension can be observed after one week. In this 
case, dyspnea, impact on daily activities and development 
of respiratory failure were indications to BPL 10,12 and actual 
improvement was noted after the procedures, allowing 
signifi cant decrease in oxygen needs.
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In conclusion, several aspects may have concurred to 
the severe hypoxemia observed, including PAP, obesity 
and anatomophysiologic changes of pregnancy. This case 
demonstrates that it is possible to carry out a full-term 
pregnancy in a patient with a serious pulmonary disease 
as PAP, as long as close monitoring of mother and fetus, as 
well as specifi c treatments (BPL included) and supplemental 
oxygenation are provided.
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